Octagon Therapeutics’ Research Alliance with Novo Nordisk

Latham & Watkins represented Octagon Therapeutics in the transaction.Octagon Therapeutics, a preclinical-stage biopharmaceutical company developing targeted medicines for autoimmune disease, has announced the initiation of a research…

This content is for members only.
Login to Read More Join Now
Laura Testa

Author: Laura Testa

This content is for members only.
Login to Read More Join Now